Literature DB >> 8636358

Progesterone stimulates the induction of human endometrial CD56+ lymphocytes in an in vitro culture system.

T Inoue1, H Kanzaki, K Imai, S Narukawa, H Katsuragawa, H Watanabe, T Hirano, T Mori.   

Abstract

An unusual population of large granular lymphocytes (LGL) with the surface phenotype CD56(bright+)/CD16-/CD3- increases in the human endometrium during the late secretory phase and early pregnancy. To identify the factor(s) that induces CD56+ LGL in the human endometrium, we isolated endometrial leukocytes from nonpregnant human endometrium and investigated changes in CD56+ cells during culture with various factors. Isolated endometrial leukocyte-rich fraction and peripheral blood mononuclear cells were cultured for 6 days in the presence of progesterone, estradiol, PRL, or hCG, then nonadherent cells were collected and examined immunocytochemically. Endometrial leukocyte-rich fractions were composed of leukocytes and endometrial stromal cells, and 53.2 +/- 5.8% of them expressed CD45 antigen before culture. Therefore, leukocytes and endometrial stromal cells were cocultured in these endometrial leukocyte-rich fraction cultures. The percentage of CD56+ cells in endometrial leukocyte-rich fractions cultured with progesterone was significantly higher than that in fractions without progesterone. On the other hand, estradiol, PRL, and hCG did not significantly induce CD56+ cells in endometrial leukocyte-rich fractions. There was no significant difference in the percentage of CD56+ cells between peripheral blood mononuclear cell cultures with and without progesterone. These findings suggest that progesterone is an important factor for the in situ proliferation or differentiation of CD56+ LGL in human endometrium.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8636358     DOI: 10.1210/jcem.81.4.8636358

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  8 in total

Review 1.  The role of NK cells in the autoimmune thyroid disease-associated pregnancy loss.

Authors:  Emiliana Konova
Journal:  Clin Rev Allergy Immunol       Date:  2010-12       Impact factor: 8.667

Review 2.  Sex steroid hormones, hormonal contraception, and the immunobiology of human immunodeficiency virus-1 infection.

Authors:  Zdenek Hel; Elizabeth Stringer; Jiri Mestecky
Journal:  Endocr Rev       Date:  2009-11-10       Impact factor: 19.871

Review 3.  The complexity of contraceptives: understanding their impact on genital immune cells and vaginal microbiota.

Authors:  Sharon L Achilles; Sharon L Hillier
Journal:  AIDS       Date:  2013-10       Impact factor: 4.177

Review 4.  Innate and adaptive immune responses in male and female reproductive tracts in homeostasis and following HIV infection.

Authors:  Philip V Nguyen; Jessica K Kafka; Victor H Ferreira; Kristy Roth; Charu Kaushic
Journal:  Cell Mol Immunol       Date:  2014-06-30       Impact factor: 11.530

Review 5.  Endocrine factors modulating immune responses in pregnancy.

Authors:  Anne Schumacher; Serban-Dan Costa; Ana Claudia Zenclussen
Journal:  Front Immunol       Date:  2014-05-08       Impact factor: 7.561

Review 6.  Effects of heme oxygenase-1 on innate and adaptive immune responses promoting pregnancy success and allograft tolerance.

Authors:  Anne Schumacher; Ana C Zenclussen
Journal:  Front Pharmacol       Date:  2015-01-06       Impact factor: 5.810

Review 7.  The regulation of ovary and conceptus on the uterine natural killer cells during early pregnancy.

Authors:  Han Gong; Yilu Chen; Jingjie Xu; Xingxing Xie; Dainan Yu; Bei Yang; Haibin Kuang
Journal:  Reprod Biol Endocrinol       Date:  2017-09-06       Impact factor: 5.211

Review 8.  Importance of the endometrial immune environment in endometrial cancer and associated therapies.

Authors:  Hannah van der Woude; Kathryn Elizabeth Hally; Margaret Jane Currie; Olivier Gasser; Claire Elizabeth Henry
Journal:  Front Oncol       Date:  2022-08-22       Impact factor: 5.738

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.